Wnt/β-Catenin in Acute Kidney Injury and Progression to Chronic Kidney Disease

Tessa Huffstater, W. David Merryman, Leslie S. Gewin

Research output: Contribution to journalReview articlepeer-review

35 Scopus citations


Summary: Acute kidney injury (AKI) portends a poor clinical prognosis and increases the risk for the development of chronic kidney disease (CKD). Currently, there are no therapies to treat AKI or prevent its progression to CKD. Wnt/β-catenin is a critical regulator of kidney development that is up-regulated after injury. Most of the literature support a beneficial role for Wnt/β-catenin in AKI, but suggest that this pathway promotes the progression of tubulointerstitial fibrosis, the hallmark of CKD progression. We review the role of Wnt/β-catenin in renal injury with a focus on its potential as a therapeutic target in AKI and in AKI to CKD transition.

Original languageEnglish
Pages (from-to)126-137
Number of pages12
JournalSeminars in Nephrology
Issue number2
StatePublished - Mar 2020


  • Acute kidney injury
  • chronic kidney disease
  • β-catenin


Dive into the research topics of 'Wnt/β-Catenin in Acute Kidney Injury and Progression to Chronic Kidney Disease'. Together they form a unique fingerprint.

Cite this